Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe latest revision entry (v3.6.4) was added to the study history, and the previous revision (v3.6.3) was removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2. This reflects a new iteration of the study record rather than a substantive change to page content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.6.2 was added in the page footer, replacing the previous v3.6.0 label, indicating a software version update rather than a content change.SummaryDifference0.1%

- Check57 days agoChange DetectedRecruitment is no longer looking for participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision entry v3.5.5 has been added to the record history, and the previous v3.5.4 entry has been removed from the list. This updates the version trail for the study record to reflect the latest revision.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry (v3.5.4) was added to the study's version history, and the previous revision (v3.5.3) was removed from the list.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.